# Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line

> **NCT07501351** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 80 (estimated)

## Conditions studied

- Hepatocellulcar Carcinoma

## Interventions

- **DRUG:** Intensified Therapy
- **DRUG:** Conversion Therapy

## Key facts

- **NCT ID:** NCT07501351
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07501351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07501351, "Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07501351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*